China has such a dominant position in active pharmaceutical ingredient (API) production that there is a risk it could "weaponise" access, according to a new congressional report. The document, from ...
Want more tried and tested recommendations from the Editors of Women’s Health? Sign up to our monthly newsletter The Edit. Click here to subscribe. No longer confined to private WhatsApp chats or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results